Skip to main content
61°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Monopar Therapeutics Inc
(NQ:
MNPR
)
2.570
-0.190 (-6.88%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Monopar Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings
February 23, 2024
U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results
February 22, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 400 points on Thursday. The Dow traded up 1.13% to 39,048.47 while the NASDAQ rose 2.93% to 16,037.52....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Cancer-Focused Monopar Therapeutics Stock Today?
February 22, 2024
Monopar Therapeutics soars 36% in premarket trading on robust volume. Exciting preclinical data reveals MNPR-101's potent anti-tumor efficacy in targeting uPAR-expressing cancers.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 22, 2024
Via
Benzinga
Crude Oil Rises 1%; US Jobless Claims Fall To 201,000
February 22, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday. The Dow traded up 0.67% to 38,872.01 while the NASDAQ rose 2.36% to 15,949.22. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Recap: Monopar Therapeutics Q3 Earnings
November 09, 2023
Via
Benzinga
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 22, 2024
Shares of Etsy, Inc.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 22, 2024
Via
Benzinga
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
February 22, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via
Benzinga
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
February 20, 2024
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Cancer Drug Focused Monopar Therapeutics Stock Trading Higher On Tuesday?
February 20, 2024
Monopar Therapeutics surges 90% premarket with 3.94 million volume after HREC clearance for Phase 1 dosimetry trial (MNPR-101-Zr) in advanced cancers.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 20, 2024
Via
Benzinga
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 20, 2024
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.
Via
Benzinga
Dow Dips Over 100 Points; US Leading Economic Index Falls In January
February 20, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Down 1%; Capital One Set To Buy Discover
February 20, 2024
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 38,607.53 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 20, 2024
Via
Benzinga
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
February 20, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
January 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 13, 2023
Via
Benzinga
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 13, 2023
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.
Via
Benzinga
Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
November 13, 2023
StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 13, 2023
Via
Benzinga
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
November 09, 2023
MNPR-101 Radiopharma Program to Enter First-in-Human Studies Potentially As Early As December of This Year Camsirubicin Phase 1b Trial Efficacy and Safety Data Highlighted at the 2023 CTOS Annual...
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
November 06, 2023
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.